← Calendar
Readoutin 14d
Sichuan Baili Pharmaceutical Co., Ltd. — BL-B01D1
Phase 3 primary completion: A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer(PANKU-Lung03).
- Date
- Dec 2026
- Type
- Readout
- Indication
- Small Cell Lung Cancer
Source ↗Add to calendar
Get told when this date moves
The weekly brief is free. Pro adds reminders 7 days and 1 day before.
More from Sichuan Baili Pharmaceutical Co., Ltd.
Dec2026
Readoutin 14d
Sichuan Baili Pharmaceutical Co., Ltd. — BL-B01D1Phase 3 primary completion: A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer(PANKU-Lung02).